Senate committee questions federal officials about dual-use research of concern procedures

"Spurred by events surrounding two controversial H5N1 transmission studies, a U.S. Senate committee [on Thursday] questioned federal officials whose agencies have a stake in dual-use research of concern (DURC) about the procedures they use to spot possible bioterror threats," CIDRAP News reports. The Senate Committee on Homeland Security and Governmental Affairs "hearing marked the first time officials have testified before Congress on the issue, and follows concerns raised in recent letters to federal officials by Rep. Jim Sensenbrenner (R-Wisc.), who has questioned the Obama administration's safeguards on DURC and has inquired about allegations of bias that arose following an expert group's recommendation that helps clear the way for publication of the two papers," the news service notes (Schnirring, 4/26).

"At the hearing, officials involved in making the decision to publish the research were queried about a letter that was leaked to the press two weeks ago," in which "Michael Osterholm, a member of the National Science Advisory Board for Biosecurity (NSABB), accused the U.S. government of stacking the decks in favor of full publication during a crucial closed door meeting in March," Nature writes (Maher, 4/27). "Part of the board's decision-making process included a classified briefing from the National Counterterrorism Center and other members of the intelligence community," Paul Keim, acting NSABB chair, said, according to CQ HealthBeat. "Although he could not go into detail, he said that the briefing left many of the board's members with the impression that the risks of redacted publication would be minimal, while the international political consequences of not publishing could be great," the news service writes (Margetta, 4/26). "Some attention was paid at the hearing to a recent policy announcement on March 29, which many see as a stopgap measure to address some of the concerns the fight over these papers has raised," Nature writes, noting officials have until May 18 to respond to the "pointed questions" posed in Sensenbrenner's letters (4/27).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New AI tool maps millions of CD8+ T cells to advance disease research